Remy Sukhija is CCO at MADRIGAL PHARMACEUTICALS, INC. (MDGL). They have made 1 open-market trade across 1 company since 2022, most recently 2023-01-16.
CIK 0001806949
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| MDGL | 15,001 | $6.7M |
Shares reported on the most recent Form 4, priced at the 2023-01-18 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| MDGL | SELL | 2022-12-23 | 2022-12-28 | $273.80 | $15.5M | +8.5% | +5.3% | -12.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.